Skip to main content

Peer Review reports

From: Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion

Original Submission
11 Oct 2023 Submitted Original manuscript
25 Nov 2023 Reviewed Reviewer Report - Yoshihiko Sakata
28 Nov 2023 Reviewed Reviewer Report
12 Dec 2023 Author responded Author comments - Panwen Tian
13 Dec 2023 Author responded Author comments - Panwen Tian
Resubmission - Version 2
12 Dec 2023 Submitted Manuscript version 2
13 Dec 2023 Author responded Author comments - Panwen Tian
Resubmission - Version 3
13 Dec 2023 Submitted Manuscript version 3
15 Dec 2023 Author responded Author comments - Panwen Tian
Resubmission - Version 4
15 Dec 2023 Submitted Manuscript version 4
4 Jan 2024 Reviewed Reviewer Report
4 Jan 2024 Reviewed Reviewer Report - Yoshihiko Sakata
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
26 Jan 2024 Editorially accepted
16 Feb 2024 Article published 10.1186/s12890-024-02886-1

You can find further information about peer review here.

Back to article page